# Neuralink Receives UK Regulatory Approval to Launch GB-PRIME International BCI Trial

> clinical trial · REPORTED · 2025-07-01

UK regulators approved Neuralink's GB-PRIME study, its first international clinical trial of the Telepathy brain-computer interface, mirroring the US PRIME Study structure. Additional international sites were established in Canada and the UAE, as the company accelerates its global clinical expansion.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://research.contrary.com/company/neuralink

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.